{"id":45615,"date":"2022-06-29T01:01:38","date_gmt":"2022-06-28T23:01:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/"},"modified":"2022-06-29T01:01:38","modified_gmt":"2022-06-28T23:01:38","slug":"civatech-oncology-selected-to-present-at-bio-international-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/","title":{"rendered":"CivaTech Oncology selected to present at BIO International Conference"},"content":{"rendered":"<div>\n<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;CivaTech Oncology Inc., a leading developer of radioactive cancer therapeutics made a presentation regarding the CivaSheet\u00ae at the annual Biotechnology Innovation Organization (BIO) Conference June 14, 2022 in San Diego California. BIO International connects top research and early stage innovations with industry and investors.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/5\/CivaTech_Logo_v2.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg\"><\/a><\/p>\n<p>\nCivaTech Oncology&#8217;s CivaSheet\u00ae was supported in development and in clinical trials by National Institutes of Health\/National Cancer Institute and the Small Business Innovation Research (SBIR). SBIR, a government program coordinated by the Small Business Administration, plays a valuable role in the start up of new companies developing meaningful products to change lives and improve cancer outcomes. SBIR grants have continued to support small businesses seeking commercialization even in the midst of a global pandemic. Funds from the NCI SBIR have helped CivaSheet\u00ae technology gain ground despite the challenging healthcare environment.\n<\/p>\n<p>\nSuzanne Babcock, CEO of CivaTech Oncology, indicated that \u201cthe role of the SBIR has been pivotal in developing the device and generating a platform that addresses many cancer types including non-small cell lung cancer, pancreatic, colorectal, head and neck, soft tissue sarcomas and more.\u201d\n<\/p>\n<p>\nCivaSheet\u00ae, a novel bio-absorbable, internal radiation treatment, is implanted in less than 30 minutes in the operating room at the time of surgery. It prevents cancer recurrence by delivering a highly targeted dose of radiation directly to the surgical margin where residual cancer cells may remain. Results from clinical trials have shown remarkable improvements in therapeutic outcomes.\n<\/p>\n<p>\nCivaSheet\u00ae is a flexible, implantable intra-operative radiation therapy device (brachytherapy) which emits unidirectional radiation using integrated gold shielding. This provides a homogenous radiation dose on one side while protecting healthy tissues. This feature is entirely unique to CivaSheet\u00ae allowing physicians to safely deliver aggressive radiation doses immediately adjacent to healthy, sensitive tissue. No complications or radiation related side effects have been reported in patients to date.\n<\/p>\n<p>\nAbout CivaTech Oncology:\n<\/p>\n<p>\nFor more information about CivaSheet or CivaTech Oncology, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.civatechoncology.com&amp;esheet=52765127&amp;newsitemid=20220628006165&amp;lan=en-US&amp;anchor=www.civatechoncology.com&amp;index=1&amp;md5=1d7dcc7e0f7110b8bb3e2308f1f0bdd8\" rel=\"nofollow noopener\" shape=\"rect\">www.civatechoncology.com<\/a> or call 919-314-1515 (Randy Harrison).\n<\/p>\n<p>\nTaylor RJ, Todor D, Kaplan BJ, Stover W, Fields EC. \u201cCivaSheet intraoperative radiation therapy for pancreatic cancer.\u201d Brachytherapy. 2022 Mar-Apr;21(2):255-259. doi: 10.1016\/j.brachy.2021.10.007\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nRandy Harrison<br \/>\n<br \/>919-314-1515\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;CivaTech Oncology Inc., a leading developer of radioactive cancer therapeutics made a presentation regarding the CivaSheet\u00ae at the annual Biotechnology Innovation Organization (BIO) Conference June 14, 2022 in San Diego California. BIO International connects top research and early stage innovations with industry and investors. CivaTech Oncology&#8217;s CivaSheet\u00ae was supported in development and in &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45615","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CivaTech Oncology selected to present at BIO International Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CivaTech Oncology selected to present at BIO International Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;CivaTech Oncology Inc., a leading developer of radioactive cancer therapeutics made a presentation regarding the CivaSheet\u00ae at the annual Biotechnology Innovation Organization (BIO) Conference June 14, 2022 in San Diego California. BIO International connects top research and early stage innovations with industry and investors. CivaTech Oncology&#8217;s CivaSheet\u00ae was supported in development and in ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-28T23:01:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"CivaTech Oncology selected to present at BIO International Conference\",\"datePublished\":\"2022-06-28T23:01:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/\"},\"wordCount\":363,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628006165\\\/en\\\/746849\\\/21\\\/CivaTech_Logo_v2.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/\",\"name\":\"CivaTech Oncology selected to present at BIO International Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628006165\\\/en\\\/746849\\\/21\\\/CivaTech_Logo_v2.jpg\",\"datePublished\":\"2022-06-28T23:01:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628006165\\\/en\\\/746849\\\/21\\\/CivaTech_Logo_v2.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220628006165\\\/en\\\/746849\\\/21\\\/CivaTech_Logo_v2.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/civatech-oncology-selected-to-present-at-bio-international-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CivaTech Oncology selected to present at BIO International Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CivaTech Oncology selected to present at BIO International Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/","og_locale":"en_US","og_type":"article","og_title":"CivaTech Oncology selected to present at BIO International Conference - Pharma Trend","og_description":"SAN DIEGO&#8211;(BUSINESS WIRE)&#8211;CivaTech Oncology Inc., a leading developer of radioactive cancer therapeutics made a presentation regarding the CivaSheet\u00ae at the annual Biotechnology Innovation Organization (BIO) Conference June 14, 2022 in San Diego California. BIO International connects top research and early stage innovations with industry and investors. CivaTech Oncology&#8217;s CivaSheet\u00ae was supported in development and in ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-28T23:01:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"CivaTech Oncology selected to present at BIO International Conference","datePublished":"2022-06-28T23:01:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/"},"wordCount":363,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/","url":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/","name":"CivaTech Oncology selected to present at BIO International Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg","datePublished":"2022-06-28T23:01:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220628006165\/en\/746849\/21\/CivaTech_Logo_v2.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/civatech-oncology-selected-to-present-at-bio-international-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"CivaTech Oncology selected to present at BIO International Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45615"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45615\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}